135 related articles for article (PubMed ID: 24375257)
41. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.
Miettinen M; Makhlouf H; Sobin LH; Lasota J
Am J Surg Pathol; 2006 Apr; 30(4):477-89. PubMed ID: 16625094
[TBL] [Abstract][Full Text] [Related]
42. Prognostic factors in surgically managed gastrointestinal stromal tumours.
Wu XJ; Zhang RX; Chen G; Fang YJ; Ding PR; Li LR; Lu ZH; Kong LH; Pan ZZ; Wan DS
J Int Med Res; 2012; 40(5):1904-11. PubMed ID: 23206474
[TBL] [Abstract][Full Text] [Related]
43. [Stromal gastrointestinal tumors: retrospective study of 24 cases].
Boudabous H; Chaker Y; Nouira R; Dziri C
Tunis Med; 2013 Nov; 91(11):661-7. PubMed ID: 24343490
[TBL] [Abstract][Full Text] [Related]
44. Surgical outcomes of gastrointestinal stromal tumors of the stomach: a single unit experience in the era of targeted drug therapy.
Huang H; Liang H; Zhan ZL; Li H; Ren XB; Hao XS
Med Oncol; 2012 Jun; 29(2):941-7. PubMed ID: 21390518
[TBL] [Abstract][Full Text] [Related]
45. Colorectal gastrointestinal stromal tumors (GISTs): a retrospective study of reported cases.
Cheng X; Chen D; Wang Y; Wang J; Lin J; Chen W
Hepatogastroenterology; 2010; 57(102-103):1128-35. PubMed ID: 21410044
[TBL] [Abstract][Full Text] [Related]
46. Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors: A single-center analysis.
Wang J; Yin Y; Shen C; Yin X; Cai Z; Pu L; Fu W; Wang Y; Zhang B
Medicine (Baltimore); 2020 Feb; 99(9):e19275. PubMed ID: 32118738
[TBL] [Abstract][Full Text] [Related]
47. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
[TBL] [Abstract][Full Text] [Related]
48. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ
World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631
[TBL] [Abstract][Full Text] [Related]
49. Prognostic factors of primary gastrointestinal stromal tumors: a cohort study based on high-volume centers.
Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
Chin J Cancer Res; 2018 Feb; 30(1):61-71. PubMed ID: 29545720
[TBL] [Abstract][Full Text] [Related]
50. Prognostic Factors of Patients with Gastric Gastrointestinal Stromal Tumor after Curative Resection: A Retrospective Analysis of 406 Consecutive Cases in a Multicenter Study.
Kim IH; Kwak SG; Chae HD
Eur Surg Res; 2015; 55(1-2):12-23. PubMed ID: 25766570
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant systemic therapy for small bowel gastrointestinal stromal tumor (GIST): Is there a survival benefit after R0 resection?
Patel DJ; Lutfi W; Eguia E; Sweigert P; Knab L; Abood G; Baker MS
Surgery; 2020 Oct; 168(4):695-700. PubMed ID: 32713755
[TBL] [Abstract][Full Text] [Related]
52. Gastrointestinal stromal tumors (GIST) related emergencies.
Sorour MA; Kassem MI; Ghazal Ael-H; El-Riwini MT; Abu Nasr A
Int J Surg; 2014; 12(4):269-80. PubMed ID: 24530605
[TBL] [Abstract][Full Text] [Related]
53. Clinical outcomes of tumor bleeding in duodenal gastrointestinal stromal tumors: a 20-year single-center experience.
Pih GY; Ahn JY; Choi JY; Na HK; Lee JH; Jung KW; Kim DH; Choi KD; Song HJ; Lee GH; Jung HY
Surg Endosc; 2021 Mar; 35(3):1190-1201. PubMed ID: 32170563
[TBL] [Abstract][Full Text] [Related]
54. A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods.
Chen T; Xu L; Ye L; Qiu H; Hu Y; Liu H; Zhou Z; Li G; Yu J
Eur J Surg Oncol; 2019 Jun; 45(6):1109-1114. PubMed ID: 30594406
[TBL] [Abstract][Full Text] [Related]
55. The role of surgical resection following imatinib treatment in patients with recurrent or metastatic gastrointestinal stromal tumors: results of propensity score analyses.
Park SJ; Ryu MH; Ryoo BY; Park YS; Sohn BS; Kim HJ; Kim CW; Kim KH; Yu CS; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2014 Dec; 21(13):4211-7. PubMed ID: 24980089
[TBL] [Abstract][Full Text] [Related]
56. Assessment of morphological CT imaging features for the prediction of risk stratification, mutations, and prognosis of gastrointestinal stromal tumors.
Cannella R; Tabone E; Porrello G; Cappello G; Gozzo C; Incorvaia L; Grignani G; Merlini A; D'Ambrosio L; Badalamenti G; Regge D; Bartolotta TV
Eur Radiol; 2021 Nov; 31(11):8554-8564. PubMed ID: 33881567
[TBL] [Abstract][Full Text] [Related]
57. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
58. [Gastrointestinal stromal tumors: clinicopathologic and survival evaluation in Rebagliati Hospital].
Manrique MN; Soriano C; Yábar A; Frisancho O; Palacios AM
Rev Gastroenterol Peru; 2012; 32(4):357-65. PubMed ID: 23307085
[TBL] [Abstract][Full Text] [Related]
59. Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors.
Cai HX; Li XQ; Wang SF
World J Gastroenterol; 2018 Nov; 24(44):5046-5056. PubMed ID: 30510379
[TBL] [Abstract][Full Text] [Related]
60. Gastrointestinal stromal tumor: 15-years' experience in a single center.
Wang M; Xu J; Zhang Y; Tu L; Qiu WQ; Wang CJ; Shen YY; Liu Q; Cao H
BMC Surg; 2014 Nov; 14():93. PubMed ID: 25403624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]